Atenolol



Atenolol





(a ten’ o lole)

Apo-Atenolol (CAN), Gen-Atenolol (CAN), Novo-Atenol (CAN), ratio-Atenolol (CAN), Tenormin

PREGNANCY CATEGORY D


Drug Classes

Antianginal

Antihypertensive

Beta1-selective adrenergic blocker


Therapeutic Actions

Blocks beta-adrenergic receptors of the sympathetic nervous system in the heart and juxtaglomerular apparatus (kidney), thus decreasing the excitability of the heart, decreasing cardiac output and oxygen consumption, decreasing the release of renin from the kidney, and lowering BP.


Indications



  • Treatment of angina pectoris due to coronary atherosclerosis


  • Hypertension, alone or with other drugs, especially diuretics


  • Treatment of MI in hemodynamically stable patients


  • Unlabeled uses: Prevention of migraine headaches; treatment of ventricular and supraventricular arrhythmias; prevention of variceal bleeding; unstable angina



Available Forms

Tablets—25, 50, 100 mg


Dosages

Adults



  • Hypertension: Initially, 50 mg PO once a day; after 1–2 wk, dose may be increased to 100 mg/day.


  • Angina pectoris: Initially, 50 mg PO daily. If optimal response is not achieved in 1 wk, increase to 100 mg daily; up to 200 mg/day may be needed.


  • Acute MI: 100 mg PO daily or 50 mg PO bid for 6–9 days or until discharge from the hospital.

Pediatric patients

Safety and efficacy not established.

Geriatric patients or patients with renal impairment

Dosage reduction is required because atenolol is excreted through the kidneys. For elderly patients, use initial dose of 25 mg/day PO. The following dosage is suggested for patients with renal impairment:

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in NURSING | Comments Off on Atenolol

Full access? Get Clinical Tree

Get Clinical Tree app for offline access